CFA
GILD icon

CWS Financial Advisors’s Gilead Sciences GILD Stock Holding History

CWS Financial Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$399K Sell
3,162
-39
-1% -$5.14K 0.09% 108
2026
Q1 		$446K Sell
3,201
-703
-18% -$98.4K 0.11% 105
2025
Q4 		$479K Buy
3,904
+714
+22% +$86.8K 0.13% 95
2025
Q3 		$354K Buy
3,190
+488
+18% +$55.5K 0.1% 109
2025
Q2 		$300K Buy
2,702
+855
+46% +$91K 0.09% 110
2025
Q1 		$207K Buy
+1,847
New +$191K 0.07% 125
2024
Q2 		– Sell
-3,767
Closed -$276K – 107
2024
Q1 		$276K Sell
3,767
-3,388
-47% -$261K 0.11% 89
2023
Q4 		$580K Sell
7,155
-369
-5% -$28.7K 0.22% 68
2023
Q3 		$564K Sell
7,524
-6
-0.1% -$461 0.23% 67
2023
Q2 		$580K Sell
7,530
-143
-2% -$11.4K 0.22% 69
2023
Q1 		$637K Buy
7,673
+197
+3% +$16.3K 0.25% 65
2022
Q4 		$483K Sell
7,476
-700
-9% -$55.4K 0.21% 74
2022
Q3 		$504K Buy
8,176
+70
+0.9% +$4.41K 0.24% 72
2022
Q2 		$501K Sell
8,106
-881
-10% -$54.5K 0.23% 80
2022
Q1 		$534K Buy
8,987
+90
+1% +$5.75K 0.2% 81
2021
Q4 		$646K Buy
+8,897
New +$613K 0.23% 74
2021
Q2 		$514K Sell
7,469
-7
-0.1% -$467 0.2% 75
2021
Q1 		$483K Buy
7,476
+75
+1% +$4.84K 0.21% 74
2020
Q4 		$431K Sell
7,401
-263
-3% -$15.9K 0.25% 73
2020
Q3 		$484K Sell
7,664
-61
-0.8% -$4.23K 0.32% 64
2020
Q2 		$594K Buy
7,725
+1,353
+21% +$104K 0.43% 50
2020
Q1 		$414K Hold
6,372
– – 0.31% 74
2019
Q4 		$414K Buy
+6,372
New +$415K 0.3% 75

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CWS Financial Advisors's GILD Position: Q2 2026 in Review

CWS Financial Advisors reduced its Gilead Sciences (GILD) stake by 1.2% in Q2 2026, selling an estimated $5.14K and leaving 3,162 shares worth $399K. The position accounts for 0.09% of the portfolio, ranked #108.

CWS Financial Advisors first reported a position in GILD in Q4 2019 and has held it in 23 quarters since. The position peaked at $646K in Q4 2021. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • CWS Financial Advisors held 3,162 shares of Gilead Sciences worth $399K as of Q2 2026.
  • CWS Financial Advisors sold 39 Gilead Sciences shares in Q2 2026, an estimated $5.14K.
  • Gilead Sciences made up 0.09% of CWS Financial Advisors's portfolio in Q2 2026, its #108 holding.
  • CWS Financial Advisors first reported a position in Gilead Sciences in Q4 2019 and has held it in 23 quarters since.
  • CWS Financial Advisors's Gilead Sciences position peaked at $646K in Q4 2021.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on CWS Financial Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.